Procaps Group S a (PROCF) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PROCF Annual Balance Sheets →
The balance sheet data below highlights changes in Procaps Group S a's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) 0 0 0
Assets
Cash And Cash Equivalents30.32
Cash & Short-term Investments30.00
Accounts receivable88.42
Notes Receivable, Current76.54
Other Current Assets0.00
Total Current Assets216.75
Equipment/Property/Plant Net93.72
Goodwill net0.00
Intangible Assets30.31
Deferred Tax Assets28.26
Other Assets, Noncurrent0.00
Total Assets411.69
Liabilities
Accounts Payable106.99
Current Tax Liabilities6.71
Short-term Debt41.41
Other Liabilities, Current0.00
Current Provisions0.32
Total Current Liabilities415.92
Long-term debt0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI0.69
Total Liabilities463.78
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity-52.09
Total Stockholder's Equity-52.09
Liabilities & Stockholder's Equity411.69
4 historic quarters locked

Sign in to unlock the full Procaps Group S a balance sheet history.

About Sofgen Pharma S A Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-028293

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.